Pentoxifylline

Product NDC: 0378-0357
11-digit product format: 003780357
Labeler code: 0378
Product ID: 0378-0357_beb53626-c84e-4571-b91d-b526323c414f
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Pentoxifylline
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: Mylan Pharmaceuticals Inc.
Application: ANDA074425
Marketing category: ANDA
Marketing start: 1997-07-08
Marketing end: 2019-05-31
Substance: PENTOXIFYLLINE
Active strength: 400 mg/1
Pharmacologic classes: Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0378-0357		D	Discontinued by firm	2026-08-17
excluded package	package	0378-0357	0378-0357-01	D	Discontinued by firm	2026-08-17
excluded package	package	0378-0357	0378-0357-05	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0378-0357-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0378-0357-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0378-0357-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0378-0357-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0378-0357-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0378-0357-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0378-0357-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0378-0357-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0378-0357-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0378-0357-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0378-0357-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0378-0357-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0378-0357-05	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0378-0357-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0378-0357-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0378-0357-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0378-0357-05	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0378-0357-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0378-0357-05	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0378-0357-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0378-0357-05	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0378-0357-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0378-0357-05	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0378-0357-01	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A074425-001	PENTOXIFYLLINE	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB		1997-07-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A074425-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	1997-07-08	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A074425-001	PENTOXIFYLLINE	400MG	TABLET, EXTENDED RELEASE / ORAL		1997-07-08	`e64feba35796…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A074425-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A074425-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074425-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074425-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074425-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074425-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074425-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074425-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074425-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074425-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074425-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074425-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074425-001	AB	1	`301d65b070ca…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A074425-001	AB	1	`a50c72e98297…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
06331747-0b00-4cea-707f-3d3bfb5d208d	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0378-0357-01	EA - Each	0378-0357	cce7da9d-a5e9-4a29-be01-730c50c8328d	1	2012-07-24
0378-0357-05	EA - Each	0378-0357	440e83d1-b753-4a4b-9df3-8f69c01553ed	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PENTOXIFYLLINE	ACTIVE INGREDIENT	SD6QCT3TSU	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
PENTOXIFYLLINE	ACTIVE INGREDIENT	SD6QCT3TSU	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
PENTOXIFYLLINE	ACTIVE MOIETY	SD6QCT3TSU	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
PENTOXIFYLLINE	ACTIVE MOIETY	SD6QCT3TSU	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
D&C RED NO. 30	INACTIVE INGREDIENT	2S42T2808B	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
D&C RED NO. 30	INACTIVE INGREDIENT	2S42T2808B	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)	INACTIVE INGREDIENT	8136Y38GY5	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)	INACTIVE INGREDIENT	8136Y38GY5	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	7
PENTOXIFYLLINE	ACTIVE INGREDIENT	SD6QCT3TSU	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
PENTOXIFYLLINE	ACTIVE MOIETY	SD6QCT3TSU	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
D&C RED NO. 30	INACTIVE INGREDIENT	2S42T2808B	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
HYDROXYETHYL CELLULOSE (140 CPS AT 5%)	INACTIVE INGREDIENT	8136Y38GY5	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
HYPROMELLOSE	INACTIVE INGREDIENT	3NXW29V3WO	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Pentoxifylline	PENTOXIFYLLINE	Rising Pharma Holdings, Inc.	cd840a2c-2a0e-4b2b-84ff-a0406bb6fa37	2026-05-15	Adverse reactions	Exact identifier application applno (ANDA): 074425 application number: ANDA074425
Pentoxifylline	PENTOXIFYLLINE	Bryant Ranch Prepack	c3ad4fb4-8995-46ab-86e9-7ec67ef607f9	2025-04-07	Adverse reactions	Exact identifier application applno (ANDA): 074425 application number: ANDA074425

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
SD6QCT3TSU	PENTOXIFYLLINE	6493-05-6	PENTOXIFYLLINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
312301	pentoxifylline 400 MG Extended Release Oral Tablet	PSN	83d5ef4b-8b46-48b6-ae5a-9a0e493350a0	1
312301	pentoxifylline 400 MG Extended Release Oral Tablet	SCD	83d5ef4b-8b46-48b6-ae5a-9a0e493350a0	1

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Pentoxifylline - Mylan Pharmaceuticals Inc.	Mylan Pharmaceuticals Inc.	2017-03-02	HUMAN PRESCRIPTION DRUG LABEL	12
PENTOXIFYLLINE EXTENDED-RELEASE TABLETS, USP 400MG RX only	NCS HealthCare of KY, Inc dba Vangard Labs	2015-08-24	HUMAN PRESCRIPTION DRUG LABEL	7
Pentoxifylline - State of Florida DOH Central Pharmacy	State of Florida DOH Central Pharmacy	2010-05-31	HUMAN PRESCRIPTION DRUG LABEL	1